Outcome measures
SECONDARY
The primary outcome measure was the area under the curve (AUC) of the total count of NY-ESO-1The protocol-specified secondary efficacy outcome measures were: (i) NY-ESO-1-specific T cell response over the first two cycles (Yes/No) as measured by ICS of PBMCs following in vitro restimulation on peptide for 10 days, (ii) CD4